Aktis Oncology Inc (AKTS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||
| Net Income | -63,731 | -43,980 | -28,641 |
| Depreciation Amortization | -2,295 | -2,506 | -2,026 |
| Accounts payable and accrued liabilities | -44 | 360 | 659 |
| Other Working Capital | -3,232 | 58,980 | -15 |
| Other Operating Activity | 5,175 | 1,908 | 19 |
| Operating Cash Flow | $-64,127 | $14,762 | $-30,004 |
| Cash Flows From Investing Activities | |||
| Change In Deposits | 75,548 | -187,538 | -65,121 |
| PPE Investments | -9,584 | -2,862 | -3,707 |
| Investing Cash Flow | $65,964 | $-190,400 | $-68,828 |
| Cash Flows From Financing Activities | |||
| Common Stock Issued | 336 | 179 | N/A |
| Other Financing Activity | -1,548 | 183,105 | 0 |
| Financing Cash Flow | $-1,212 | $183,284 | $N/A |
| Beginning Cash Position | 38,308 | 30,662 | 129,494 |
| End Cash Position | 38,933 | 38,308 | 30,662 |
| Net Cash Flow | $625 | $7,646 | $-98,832 |
| Free Cash Flow | |||
| Operating Cash Flow | -64,127 | 14,762 | -30,004 |
| Capital Expenditure | -9,584 | -2,862 | -3,764 |
| Free Cash Flow | -73,711 | 11,900 | -33,768 |